Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRAGE: Mirtazapine for Chronic Insomnia in Older Adults
NCT05247697Phase 1Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Oct 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Insomnia comparing Mirtazapine Arm with Placebo Arm (2 arms). Primary endpoints: Insomnia Severity Index at Day 36 and Pittsburgh Sleep Quality Index at Day 36. Started Oct 2022; status: completed.
02
Drugs
mirtazapine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT05247697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05247697.